These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12964678)

  • 21. Soaring ADAP costs continue to force restrictions in access.
    AIDS Policy Law; 1999 Mar; 14(5):1, 9. PubMed ID: 11366440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 23. The cost of silence?
    Nature; 2008 Dec; 456(7222):545. PubMed ID: 19052574
    [No Abstract]   [Full Text] [Related]  

  • 24. The first billion-dollar AIDS drug?
    Marks S
    J Int Assoc Physicians AIDS Care; 1996 Sep; 2(9):60-1. PubMed ID: 11363894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectacular failure--a view from the epicenter.
    Crewe M
    Yale J Health Policy Law Ethics; 2004; 4(1):157-63. PubMed ID: 15052866
    [No Abstract]   [Full Text] [Related]  

  • 26. Merck broke AIDS drug price promise, says MSF.
    Ahmad K
    Lancet; 2004 Mar; 363(9412):872. PubMed ID: 15032243
    [No Abstract]   [Full Text] [Related]  

  • 27. How can resources be mobilized to confront a global health emergency?--an introduction to the problem.
    Currie P
    Yale J Health Policy Law Ethics; 2004; 4(1):125-8. PubMed ID: 15052862
    [No Abstract]   [Full Text] [Related]  

  • 28. Activists block Gore's office to protest terms of Africa deal.
    James JS
    AIDS Treat News; 1999 Sep; (No 326):5. PubMed ID: 11366580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A remedy beyond lower cost drugs.
    Zuniga JM
    IAPAC Mon; 2001 Sep; 7(9):267. PubMed ID: 11708270
    [No Abstract]   [Full Text] [Related]  

  • 30. [GlaxoSmithKline again lowers prices of drugs for HIV/AIDS and malaria].
    Krankenpfl J; 2002; 40(7-9):222-3. PubMed ID: 12514863
    [No Abstract]   [Full Text] [Related]  

  • 31. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 32. Big five to cut cost of AIDS drugs.
    S Afr Med J; 2000 Jun; 90(6):582-3. PubMed ID: 10918884
    [No Abstract]   [Full Text] [Related]  

  • 33. Trip into the unknown.
    Anderson T
    Nature; 2007 Nov; 450(7169):471. PubMed ID: 18033269
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical interests versus AIDS in Africa.
    Lancet; 2003 Jul; 362(9378):89. PubMed ID: 12867102
    [No Abstract]   [Full Text] [Related]  

  • 35. Leading businesses confront AIDS in Africa.
    AIDS Policy Law; 2003 Jan; 18(2):8. PubMed ID: 12599305
    [No Abstract]   [Full Text] [Related]  

  • 36. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress at last? South Africa relents on HIV drugs.
    Huff B
    GMHC Treat Issues; 2003; 17(7-8):16, 15. PubMed ID: 14686317
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS treatment: staying the course.
    Check E
    Nature; 2006 Aug; 442(7103):617-9. PubMed ID: 16900174
    [No Abstract]   [Full Text] [Related]  

  • 39. The Bush Administration's global AIDS promises--and praxis.
    Russell A
    Yale J Health Policy Law Ethics; 2004; 4(1):133-45. PubMed ID: 15052864
    [No Abstract]   [Full Text] [Related]  

  • 40. Twenty-five years of AIDS.
    Cameron DW
    CMAJ; 2006 Aug; 175(3):225, 227. PubMed ID: 16880433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.